secwatch / observer
8-K filed May 28, 2026, 8:00 AM ET ticker BCDA CIK 0000925741
regulatory confidence high sentiment positive materiality 0.70

BioCardia Japan PMDA supports CardiAMP cell therapy submission for HFrEF; submission planned Q4 2026

BioCardia, Inc.

item 7.01item 9.01

Machine-readable event card

schema_version
secwatch.filing_event.v1
accession
0001437749-26-018670
form_type
8-K
ticker
BCDA
cik
0000925741
company_name
BioCardia, Inc.
filed_at
2026-05-28T12:00:11+00:00
discovered_at
2026-05-28T12:05:00.407978+00:00
generated_at
2026-05-28T12:06:59.983266+00:00
sec_items
["7.01", "9.01"]
event_type
regulatory
sentiment
positive
materiality_score
0.7
calibrated_materiality_score
0.7
confidence
high
secwatch_canonical_url
https://secwatch.observer/filing/0001437749-26-018670
json_url
https://secwatch.observer/filing/0001437749-26-018670.json
markdown_url
https://secwatch.observer/filing/0001437749-26-018670.md
text_url
https://secwatch.observer/filing/0001437749-26-018670.txt
edgar_index_url
https://www.sec.gov/Archives/edgar/data/925741/000143774926018670/0001437749-26-018670-index.htm
edgar_primary_document_url
https://www.sec.gov/Archives/edgar/data/925741/000143774926018670/bcda20260528_8k.htm
generated_by_model
deepseek-v4-flash:cloud@v2
review_status
machine_generated
human_reviewed
false
corrected
false
correction_note
null
correction_timestamp
null
superseded_by
null
JSON Markdown Plain text

Comparable filings

GENC

Gencor receives NYSE American delinquency notice for late Q2 2026 10-Q filing

GENCOR INDUSTRIES INC June 1, 2026, 4:09 PM ET regulatory Items 3.01, 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: regulatory similar materiality

Filing page SEC filing

NJR

NJNG files base rate case seeking $157.6M increase; offers 8.9% winter bill cut

NEW JERSEY RESOURCES CORP June 1, 2026, 4:03 PM ET regulatory Items 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: regulatory similar materiality

Filing page SEC filing

ELTP

Elite Pharmaceuticals files ANDA for generic anticoagulant; $26B brand market, no generic available

ELITE PHARMACEUTICALS INC /NV/ June 1, 2026, 7:00 AM ET regulatory Items 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: regulatory similar materiality

Filing page SEC filing

ATNM

Actinium receives NYSE American non-compliance notice for low stockholders' equity; must submit plan by June 26

Actinium Pharmaceuticals, Inc. May 29, 2026, 5:10 PM ET regulatory Items 3.01, 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: regulatory similar materiality

Filing page SEC filing

REPL

Replimune to resubmit RP1 BLA for advanced melanoma; FDA agrees to prioritize review

Replimune Group, Inc. May 29, 2026, 9:56 AM ET regulatory Items 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: regulatory similar materiality

Filing page SEC filing

BDX

BD resumes ChloraPrep shipments after voluntary hold; all final release testing acceptable

BECTON DICKINSON & CO May 29, 2026, 8:39 AM ET regulatory Items 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: regulatory similar materiality

Filing page SEC filing

CDT

CDT Equity receives Nasdaq deficiency letter for late Q1 10-Q filing; has until July 20 to submit plan

CDT Equity Inc. May 28, 2026, 4:30 PM ET regulatory Items 3.01, 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: regulatory similar materiality

Filing page SEC filing

TMC

NOAA certifies TMC USA's exploration license for USA B; 1.02B tonne nodule resource

TMC the metals Co Inc. May 28, 2026, 9:04 AM ET regulatory Items 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: regulatory similar materiality

Filing page SEC filing

Source: SEC EDGAR
accession 0001437749-26-018670
view filing index on sec.gov
view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.